BASECARE-B (02170) surged nearly 6% in late trading. As of press time, the stock was up 4.83% to HK$3.91, with trading volume reaching HK$4.3854 million.

On the news front, BASECARE announced that its Gems Culture Medium (Embryo Handling Solution VitBase) has officially received a registration certificate issued by the National Medical Products Administration (NMPA). This represents not only a milestone event in China's assisted reproduction field, but also marks the official entry of domestic high-end culture media into the international leading ranks, completely breaking the monopoly of imported brands that has lasted for over thirty years.

It is reported that VitBase belongs to the star product GEMS series developed under BASECARE's international brand BMX. BASECARE's Gems Culture Medium is one of the culture media favored by Chinese embryologists and has a history of 30 years to date. Currently, 11 models have obtained EU CE certification, 8 have been approved by the US FDA, and 11 comply with Australian TGA standards, enabling coverage of the entire assisted reproduction process.